Bionor Pharma
Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.med. and Dr.philos. in protein and lipid research, Lars Høie.
Link from a Wikipage to another Wikipage
primaryTopic
Bionor Pharma
Bionor Holding AS is a Norwegian biotechnology company, developing vaccines targeted at rapidly mutating virus infections such as HIV, Hepatitis C and Influenza. The company is also a leader in soy technology and has developed patented products for improved health and prevention of lifestyle-related diseases. It was founded by Cand.med. and Dr.philos. in protein and lipid research, Lars Høie.
has abstract
Bionor Holding AS is a Norwegi ...... and lipid research, Lars Høie.
@en
assets ($)
equity ($)
founding date
1993-01-02
founding year
industry
key person
net income ($)
number of employees
operating income ($)
revenue ($)
1.09499E8
type
Link from a Wikipage to an external page
Wikipage page ID
39,294,179
page length (characters) of wiki page
Wikipage revision ID
1,000,759,609
Link from a Wikipage to another Wikipage
assets
NOK 253 395 million
@en
equity
NOK 203 320 million
@en
foundation
1993-01-02
homepage
industry
key people
Birger Sørensen , Dag Arne Wivelstad, Aslak Aslaksen, Per Bengtsson
@en
logo
@en
name
Bionor Holding AS
@en
net income
NOK 49 020 million
@en
num employees
operating income
NOK 46 057 million
@en
revenue
type
wikiPageUsesTemplate
subject
hypernym
comment
Bionor Holding AS is a Norwegi ...... and lipid research, Lars Høie.
@en
label
Bionor Pharma
@en
sameAs
closeMatch
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Bionor Holding AS
@en